An Official Website of the United States Government
Company Information:
Name:
INVENIO THERAPEUTICS, INC.
Address:
1100 CEDAR AVE, STE 285
CLEVELAND, OH 44106-3007
CLEVELAND, OH 44106-3007
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Plant-derived differentiation agents for AML
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$142,460.00
Abstract:
DESCRIPTION (provided by applicant): Plant-derived compounds, particularly alkaloids, have historically been a successful source of currently used therapeutics. Recently, a plant-derived alkaloid was identified that is a potent acute myeloid leukemia (AML)
differentiation-inducing compound.… More
Novel differentiation therapy for AML
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$128,230.00
Abstract:
DESCRIPTION (provided by applicant): Acute myeloid leukemia (AML) is one of the most common forms of leukemia in adults and despite advances in treatment the 5 year survival is less than 20-50% in adults and significantly lower in the elderly. The remarkab
le success in treating one relatively… More
Natural product-derived differentiation agents for AML
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Mukesh K. Agarwal – 216-496-9053
Award Amount:
$853,202.00
Abstract:
DESCRIPTION (provided by applicant): Though AML is one of the most common forms of leukemia in adults; the 5 year survival is less than 20-50% in adults and significantly lowers in the elderly. The remarkable success in treating one relatively uncommon subset of AML, acute promyelocytic leukemia… More